BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 16203795)

  • 1. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer outcome and subtype classification by gene expression.
    Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
    Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
    J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
    Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.
    Veltman JA; Fridlyand J; Pejavar S; Olshen AB; Korkola JE; DeVries S; Carroll P; Kuo WL; Pinkel D; Albertson D; Cordon-Cardo C; Jain AN; Waldman FM
    Cancer Res; 2003 Jun; 63(11):2872-80. PubMed ID: 12782593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular signature in superficial bladder carcinoma predicts clinical outcome.
    Dyrskjøt L; Zieger K; Kruhøffer M; Thykjaer T; Jensen JL; Primdahl H; Aziz N; Marcussen N; Møller K; Orntoft TF
    Clin Cancer Res; 2005 Jun; 11(11):4029-36. PubMed ID: 15930337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall genomic pattern is a predictor of outcome in neuroblastoma.
    Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
    J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
    Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
    Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies.
    Costa JL; Meijer G; Ylstra B; Caldas C
    Semin Radiat Oncol; 2008 Apr; 18(2):98-104. PubMed ID: 18314064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Zieger K; Dyrskjøt L; Wiuf C; Jensen JL; Andersen CL; Jensen KM; Ørntoft TF
    Clin Cancer Res; 2005 Nov; 11(21):7709-19. PubMed ID: 16278391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
    Kawaguchi K; Honda M; Yamashita T; Shirota Y; Kaneko S
    Biochem Biophys Res Commun; 2005 Apr; 329(1):370-80. PubMed ID: 15721316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
    Kim MY; Yim SH; Kwon MS; Kim TM; Shin SH; Kang HM; Lee C; Chung YJ
    Gastroenterology; 2006 Dec; 131(6):1913-24. PubMed ID: 17087931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
    Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
    Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.